Moderna, Inc Q2 Loss Decreases
(RTTNews) - Moderna, Inc (MRNA) released Loss for second quarter of -$782 million
The company's earnings totaled -$782 million, or -$1.97 per share. This compares with -$825 million, or -$2.13 per share, last year.
The company's revenue for the period rose 2.1% to $145 million from $142 million last year.
Moderna, Inc earnings at a glance (GAAP) :
-Earnings: -$782 Mln. vs. -$825 Mln. last year. -EPS: -$1.97 vs. -$2.13 last year. -Revenue: $145 Mln vs. $142 Mln last year.
The Company is targeting up to 10% growth from 2025 revenue and expects 2026 revenue split to be approximately 50% U.S. and approximately 50% international. Moderna expects approximately 55% of its second half 2026 revenue to be recognized in the third quarter.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.